Table of Contents

• 68Ga-PSMA PET/CT-avid Tumour Volume: A Potential Prognostic Biomarker in Metastatic Hormone Sensitive Prostate Cancer

  Greta Beale, Alexander Yuile ... David L Chan

  Prostate-specific membrane antigen (PSMA) PET/CT provides sensitive whole-body assessment in prostate cancer, yet the prognostic role of total tumour volume (TTV) is not fully defined in metastatic hormone-sensitive disease and needs further exploration. ...

  RESEARCH | Published: 28 Jun 2026

  Annals of Urologic Oncology, Articles, Online First

  Full Text   PDF(667KB)   Views：204Downloads：4

• Robot-Assisted Adrenalectomy for a Giant Adrenal Myelolipoma: One of the Largest Tumors Removed by a Minimally Invasive Approach

  Avishek Mandal, Shikhar Chohan ... Pawan Vasudeva

  Adrenal myelolipomas are rare, benign tumors composed of adipose and hematopoietic tissue. While often asymptomatic, tumors larger than 10 cm-termed "giant"-may require surgical removal owing to the mass effect. The robotic approach to adrenalectomy offers a minimally invasive alternative to open surgery. This case is reported for its novelty, being one of the largest adrenal myelolipoma removed r...

  CASE REPORT | Published: 26 May 2026

  Annals of Urologic Oncology, Articles, Online First

  Full Text   PDF(2220KB)   Views：563Downloads：4

• Targeting Cellular Senescence in Prostate Cancer: Molecular Landscape and Therapeutic Avenues

  Haneen Hossam, Bandar Alattaibi

  Prostate cancer is one of the major causes of cancer morbidity and mortality in men, especially at advanced stages where treatment fails. Despite the fact that the existing treatment options, such as androgen deprivation therapy, chemotherapy, radiotherapy, PARP inhibitors, and targeted agents, can successfully manage the disease progression, resistance and recurrence are frequent. Recent evidence...

  REVIEW | Published: 07 Feb 2026

  Annals of Urologic Oncology, Articles, Online First

  Full Text   PDF(2550KB)   Views：2843Downloads：7

• Adenoid Cystic (Basal Cell) Carcinoma of the Prostate: A Rare Entity with Diagnostic Challenges and Therapeutic Uncertainty

  Shabana Andleeb Ansari, Mohd. Mubashir Ali Khan ... Nagma Parveen

  Adenoid cystic carcinoma (ACC), also referred to as basal cell carcinoma (BCC) of the prostate— a term used synonymously in the literature to describe the same clinicopathological entity— is an exceedingly rare malignant neoplasm. Initially described in the salivary glands by Billroth in 1859, ACC is characterized by cribriform, glandular, and basaloid architectural patterns. Prostatic involvement...

  CASE REPORT | Published: 18 Jan 2026

  Annals of Urologic Oncology, Articles, Online First

  Full Text   PDF(1040KB)   Views：1657Downloads：4